Pharmaceutical composition for anti-inflammatory, and improvement of bone tissue generation or cartilage tissue generation comprising purified fraction materials from Stauntonia hexaphylla leaves or flavonoid compounds and caffeic acid compounds separated therefrom as active ingredients
KR20200032002A
Novel thiazole derivatives and pharmaceutically acceptable salts thereof
CN112118840A
Pharmaceutical composition for preventing or treating solid cancer or leukemia comprising 1, 2-naphthoquinone derivative compound
KR20190050674A
Pharmaceutical composition for anti-inflammatory, and improvement of bone tissue generation or cartilage tissue generation comprising purified fraction materials from Stauntonia hexaphylla leaves or flavonoid compounds and caffeic acid compounds separated therefrom as active ingredients
KR20190005678A
Novel nicotinate salt of O-desmethylvenlafaxine and method for preparing the same
KR20190005679A
Novel 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine salt and method for preparing the same
KR20180100869A
Pharmaceutical composition of particle size controlled pirfenidone with improved compressibility and method for preparing the same
KR20180077998A
Novel caffeic acid compound from Stauntonia hexaphyll leaf extract and composition for anti-inflammatory, and improvement of bone tissue generation or cartilage tissue generation
KR20180077997A
Novel flavonoid compound from Stauntonia hexaphyll leaf extract and composition for anti-inflammatory, and improvement of bone tissue generation or cartilage tissue generation
KR20180055945A
Composition for Improving hepatic function Including Extract of Salvia Militorhiza Bunge and Method for Preparation of the Same
KR20180023337A
Sustained release-microsphere comprising oils containing C18:1, C18:1(OH) or C18:2 long chain fatty acid and method for preparing the same
KR20160148936A
a novel compound (KS 513) isolated from the extract of Pseudolysimachion rotundum var. subintegrum and the composition comprising the same as an active ingredient for preventing or treating allergy disease, inflammatory disease, asthma or chronic obstructive pulmonary disease
KR20160080794A
Stable pharmaceutical composition comprising Ursodeoxycholic acid and method for preparing the same
KR20160012498A
a novel compound isolated from the extract of Pseudolysimachion rotundum var. subintegrum and the composition comprising the same as an active ingredient for preventing or treating allergy disease, inflammatory disease, asthma or chronic obstructive pulmonary disease
WO2011049309A2
Pharmaceutical composition with both immediate and extended release characteristics
